Rian Hollister: PlasmaFlow As An Option for Continued DVT Prevention
Rian Hollister, Territory Manager at Recon Supply, shared on LinkedIn:
”To all my fellow veterans, ask your VA providers/staff about PlasmaFlow as an option for continued DVT prevention from hospital/medical facility to home.
‘U.S. Centers for Medicare and Medicaid Services (CMS) declared deep vein thrombosis (DVT) a Never Event in 2008, yet it remains the leading cause of preventable death in hospitalized patients each year.’
‘The PlasmaFlow™ Portable Compression Device can reduce DVT risk by providing hospital-quality vascular compression therapy to patients wherever they recover.
DVT risk doesn’t end when a patient is discharged.
With more high-risk surgeries moving from inpatient to outpatient settings, effective compression therapy after discharge is critical.
CHEST guidelines recommend extending thromboprophylaxis in the outpatient period for up to 35 days from the day of surgery for patients undergoing major orthopedic surgery.’
- 60% of HA-VTEs occur after patients have been discharged.
- As many as 70% of HA-VTE cases in patients could be prevented.
“Healthcare-associated venous thromboembolism (HA-VTE) leads to approximately 100,000 premature deaths annually.”
Mean time to presentation for symptomatic DVT:
Total Knee Arthroplasty (TKA) patients = 19.5 days
Total Hip Arthroplasty (THA) patients = 22.5 days
‘The PlasmaFlow™ Portable Compression Device provides continuous DVT prevention for patients returning home to recover.
This portable compression device is comfortable and convenient, ensuring better protection for patients and peace of mind for providers.”’
Stay updated with Hemostasis Today.
-
Oct 13, 2026, 14:14ESPHO at MAX Cancer Congress 2026: Advancing Ethiopian Pediatric Oncology on the Global Stage
-
Oct 13, 2026, 14:05Antonella Cordoba: WFH Representatives Visit the Hemophilia Foundation of Argentina
-
Oct 13, 2026, 13:56John Strouse: Screening for FNAIT – What HDN Teaches Us About Preventing Newborn Intracranial Hemorrhage
-
Oct 13, 2026, 12:29Mariam Al Mansoori: 5th International Hemophilia Conference
-
Oct 13, 2026, 12:13Hemophilia Outreach of Wisconsin Attends VWD Connect Conference
-
Oct 13, 2026, 11:41Abhishek Kumar: How Three Hemophilia Patients Helped Secure Life-Saving Treatment in Bihar
-
Oct 13, 2026, 11:24Brandon Daniel D’Costa: Building Stronger Stakeholder Relationships Through Empathy and Open Communication
-
Oct 13, 2026, 11:08Renel Tique: 5th International Conference on Hemophilia and Rare Bleeding Disorders
-
Oct 13, 2026, 02:01Nour Al-Mozain: Is It Really Anti-D? – Unraveling Auto-Anti-LW in the Transfusion Laboratory